---
figid: PMC5528615__MOL2-8-1084-g001
figlink: /pmc/articles/PMC5528615/figure/mol22014861084-fig-0001/
number: F1
caption: 'Diagram of clinically detected mechanisms of acquired resistance to anti‐EGFR
  antibody therapy in colorectal cancers. (A) Amplification/activation of MET bypasses
  the blockade of the EGFR pathway. (B) Amplification/activation of HER2 bypasses
  the blockade of the EGFR pathway. (C) The S492 EGFR mutation prevents cetuximab
  from binding to the receptor. (D) Amplification of KRAS activates the RAS‐RAF‐MEK
  pathway. (E) Mutations in RAS constitutively activate the RAS‐RAF‐MEK pathway. E:
  EGFR ligands.'
pmcid: PMC5528615
papertitle: Acquired resistance to EGFR‐targeted therapies in colorectal cancer.
reftext: Beth O. Van Emburgh, et al. Mol Oncol. 2014 Sep;8(6):1084-1094.
pmc_ranked_result_index: '74696'
pathway_score: 0.9759412
filename: MOL2-8-1084-g001.jpg
figtitle: Diagram of clinically detected mechanisms of acquired resistance to anti‐EGFR
  antibody therapy in colorectal cancers
year: '2014'
organisms: Homo sapiens
ndex: 7286ad76-debf-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5528615__MOL2-8-1084-g001.html
  '@type': Dataset
  description: 'Diagram of clinically detected mechanisms of acquired resistance to
    anti‐EGFR antibody therapy in colorectal cancers. (A) Amplification/activation
    of MET bypasses the blockade of the EGFR pathway. (B) Amplification/activation
    of HER2 bypasses the blockade of the EGFR pathway. (C) The S492 EGFR mutation
    prevents cetuximab from binding to the receptor. (D) Amplification of KRAS activates
    the RAS‐RAF‐MEK pathway. (E) Mutations in RAS constitutively activate the RAS‐RAF‐MEK
    pathway. E: EGFR ligands.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NRAS
  - PIK3CD
  - PIK3R4
  - PIK3R5
  - MTOR
  - PIK3CA
  - PIK3CB
  - AKT1
  - AKT3
  - PIK3R6
  - KRAS
  - PIK3R3
  - MET
  - MAPK1
  - PIK3CG
  - MAPK3
  - ERBB2
  - MAP2K2
  - RAF1
  - BRAF
  - HRAS
  - ARAF
  - AKT2
  - EGFR
  - MAP2K1
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: NRAS
  symbol: NRAS
  source: hgnc_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: KRAS
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC5528615__F1
redirect_from: /figures/PMC5528615__F1
figtype: Figure
---
